Possible therapeutic intervention with inhibitors and promoters of phospholipase A2 subtypes.

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Possible therapeutic intervention with inhibitors and promoters of phospholipase A2 subtypes. / Kolko, Miriam; Zhan, C; Andreasen, JR; Prause, JU; Heegaard, S.

In: Ugeskrift for Laeger, 01.01.2007.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Kolko, M, Zhan, C, Andreasen, JR, Prause, JU & Heegaard, S 2007, 'Possible therapeutic intervention with inhibitors and promoters of phospholipase A2 subtypes.', Ugeskrift for Laeger.

APA

Kolko, M., Zhan, C., Andreasen, JR., Prause, JU., & Heegaard, S. (2007). Possible therapeutic intervention with inhibitors and promoters of phospholipase A2 subtypes. Ugeskrift for Laeger.

Vancouver

Kolko M, Zhan C, Andreasen JR, Prause JU, Heegaard S. Possible therapeutic intervention with inhibitors and promoters of phospholipase A2 subtypes. Ugeskrift for Laeger. 2007 Jan 1.

Author

Kolko, Miriam ; Zhan, C ; Andreasen, JR ; Prause, JU ; Heegaard, S. / Possible therapeutic intervention with inhibitors and promoters of phospholipase A2 subtypes. In: Ugeskrift for Laeger. 2007.

Bibtex

@article{6747cc232cb8475386dad899a8966c59,
title = "Possible therapeutic intervention with inhibitors and promoters of phospholipase A2 subtypes.",
abstract = "Phospholipase A2 (PLA2) is a group of enzymes discovered more than a century ago in insect and snake poison. Not more than 20 years ago they were identified in vertebrates, and during the last five years, research has accelerated in relation to isolating and cloning several members of this super-family in humans. PLA2 inhibitors are in the process of being developed for pharmaceutical use. The purpose of this review is to outline the relevance and prospectives of PLA2 in a clinical perspective.",
author = "Miriam Kolko and C Zhan and JR Andreasen and JU Prause and S Heegaard",
year = "2007",
month = jan,
day = "1",
language = "English",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",

}

RIS

TY - JOUR

T1 - Possible therapeutic intervention with inhibitors and promoters of phospholipase A2 subtypes.

AU - Kolko, Miriam

AU - Zhan, C

AU - Andreasen, JR

AU - Prause, JU

AU - Heegaard, S

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Phospholipase A2 (PLA2) is a group of enzymes discovered more than a century ago in insect and snake poison. Not more than 20 years ago they were identified in vertebrates, and during the last five years, research has accelerated in relation to isolating and cloning several members of this super-family in humans. PLA2 inhibitors are in the process of being developed for pharmaceutical use. The purpose of this review is to outline the relevance and prospectives of PLA2 in a clinical perspective.

AB - Phospholipase A2 (PLA2) is a group of enzymes discovered more than a century ago in insect and snake poison. Not more than 20 years ago they were identified in vertebrates, and during the last five years, research has accelerated in relation to isolating and cloning several members of this super-family in humans. PLA2 inhibitors are in the process of being developed for pharmaceutical use. The purpose of this review is to outline the relevance and prospectives of PLA2 in a clinical perspective.

M3 - Journal article

C2 - 17227656

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

ER -

ID: 336817370